Mesenchymal stromal cell 'licensing': a multistep process.
about
Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferationMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface DiseasesThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisEndometrial stem/progenitor cells: the first 10 yearsStrategies to improve the immunosuppressive properties of human mesenchymal stem cellsBottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal CellsMesenchymal stem cells, autoimmunity and rheumatoid arthritisHuman mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applicationsSpheroid Culture of Mesenchymal Stem CellsActivation, homing, and role of the mesenchymal stem cells in the inflammatory environmentMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentMesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis ProgressionPreconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune ResponseMesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challengesInternational Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming.Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.The stem cell secretome and its role in brain repair.Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic propertiesHuman limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto's thyroiditis.Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrowImmune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational ageHuman mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro StudyEmerging roles for multipotent, bone marrow-derived stromal cells in host defenseIn quest of optimal drug-supported and targeted bone regeneration in the cranio facial area: a review of techniques and methods.The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels.Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells.Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.Soft Elasticity-Associated Signaling and Bone Morphogenic Protein 2 Are Key Regulators of Mesenchymal Stem Cell Spheroidal Aggregates.Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controlsImmunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationTranscriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients
P2860
Q24297200-4BB4FD50-01A1-4DAD-B67A-AB2BC677605BQ26746104-9C1E9B85-EC46-47A4-9126-22A42C862EC3Q26750660-0821BFE6-721E-43E0-926A-2278C43EDC36Q26773017-BEBDC9FA-7CFA-4A51-B705-8F23BA30B9F7Q26778310-441445E5-0D92-4752-8CBB-47D3F12BAB5AQ26786626-E47D9588-E62E-466E-AF07-3ED14C20C4DEQ26798278-57E1B6C9-6AE5-4758-B380-F016D42913FBQ26828950-D2F97AF0-0D01-4A07-8292-341AD8192107Q27004008-389D8112-5D8A-4CCB-A26A-65E8E0C8E0E2Q27023276-0FB64502-6A3B-41D5-9743-04A1050B502BQ28067094-F0E7AFEF-39F5-4960-9F9C-62F98025E5DDQ28073613-FD92C18C-1783-4CCB-97E5-B80C1262078BQ28078360-46C2F968-8BB5-493D-B0EC-D19FFE22483FQ28078893-84196B43-8E93-43AF-9C1E-8A408FDE4248Q30009860-79777B10-8312-40AA-BDB1-A4AE5EDB9C5CQ30488740-FBD65B2E-00BF-48CA-9F47-AE8BAADECBF4Q33576188-0F187971-2B6F-4897-A69C-D152B465278BQ33722207-FB85384E-09E3-427F-A5EC-77E35517DF89Q33771698-8C8A1913-EFBA-42E7-840D-1903CC3901EFQ33861809-56EDE2B1-38A6-4FDE-8FE0-6ADBDCC74CE7Q33868555-C926F894-7E3F-417B-8526-AC1A773909A6Q33872923-92756913-3C7A-4C74-A4C5-511D7A552CC9Q34261568-4CE297ED-2916-4D54-AC5D-C8B49E7D6041Q34751229-E6B8050A-10CB-4260-ACC0-2D2669D9CF31Q35007600-0C19EE31-D2A6-4684-B5D8-21CB07A4689EQ35206941-034D3B56-5474-42E9-A46D-C5EC93C2BFE1Q35739571-43DAE817-F95E-4271-AA6C-B302AE401EF7Q35802197-DEE0BD45-8C8F-4882-99B9-F31749DA013AQ35874102-DA7F86CA-12DF-471B-9C59-526F9970603BQ36054671-BFFA95DE-A545-4941-94FC-5E94CC1EA211Q36067836-19229E39-6E87-495F-9B4D-ABF6D62B6860Q36070752-6568F80A-8CD1-4FD7-B413-0BE628D4C2E5Q36142956-8F7BB9C0-41E5-4C68-A3E9-5EA5EA252461Q36260708-879D28BA-E42A-4450-BE46-A2D66004D153Q36506274-9FDB778E-3185-4E81-80A9-FC97E5CBF7ABQ36655811-6C66FC5A-BC63-4CDD-B6BB-503363EAC19AQ36806575-A60A476B-5681-4006-ABE4-1F17358C878BQ36889803-E8A04FBE-9571-406E-B744-41F1A79E9AD0Q36998274-C535390B-5C2C-43FA-8F49-3E5E4F7BF57BQ37089931-8E168A41-CA82-42E8-86BE-F78C841C5614
P2860
Mesenchymal stromal cell 'licensing': a multistep process.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mesenchymal stromal cell 'licensing': a multistep process.
@en
Mesenchymal stromal cell 'licensing': a multistep process.
@nl
type
label
Mesenchymal stromal cell 'licensing': a multistep process.
@en
Mesenchymal stromal cell 'licensing': a multistep process.
@nl
prefLabel
Mesenchymal stromal cell 'licensing': a multistep process.
@en
Mesenchymal stromal cell 'licensing': a multistep process.
@nl
P356
P1433
P1476
Mesenchymal stromal cell 'licensing': a multistep process.
@en
P2093
M Krampera
P2888
P304
P356
10.1038/LEU.2011.108
P577
2011-05-27T00:00:00Z
P5875
P6179
1028464217